{"id":"e401d2c7-b035-4dea-9b60-ae0d2bb9b99b","name":"Stereotaxis","slug":"stereotaxis","description":"Stereotaxis is an American medical device company based in St. Louis, Missouri, developing magnetic navigation technology for robotic cardiology procedures. Its [Genesis RMN](/models/genesis-rmn) system uses robotically controlled magnets to guide flexible catheters with magnetic tips during cardiac ablation procedures, and received FDA clearance and NMPA approval in China.","status":"public (NYSE American: STXS)","founded":1990,"hq":"St. Louis, MO, USA","hqLat":38.6254063,"hqLng":-90.190009,"hqGeocodedAt":"2026-08-05T14:49:41.537Z","hqAddress":null,"hqPrecision":null,"website":"stereotaxis.com","fundingTotal":null,"type":"both","roles":["robot_maker","robot_operator"],"reviewStatus":"reviewed","heatIndex":50,"lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://www.globenewswire.com/news-release/2025/11/10/stereotaxis-genesisx-fda-clearance","title":"Stereotaxis GenesisX RMN system receives US FDA 510(k) clearance (Nov 10 2025)","sourceName":"Stereotaxis (GlobeNewswire)"},{"url":"https://www.globenewswire.com/news-release/2026/01/06/stereotaxis-magic-catheter-fda","title":"Stereotaxis MAGiC magnetic ablation catheter receives FDA approval (Jan 6 2026)","sourceName":"Stereotaxis (GlobeNewswire)"},{"url":"https://www.globenewswire.com/news-release/2026/05/12/stereotaxis-q1-2026-results","title":"Stereotaxis Q1 2026 results (revenue $6.3M; Robocath acquisition agreement)","sourceName":"Stereotaxis (GlobeNewswire)"}],"keyFacts":[{"label":"Product","value":"Genesis RMN / GenesisX Robotic Magnetic Navigation"},{"label":"Gating events","value":"GenesisX CE Aug 2024 + FDA 510(k) Nov 10 2025; MAGiC FDA Jan 6 2026."},{"label":"Stock listing","value":"NYSE American: STXS"},{"label":"Installed base","value":">100 RMN systems installed"},{"label":"CEO","value":"David Fischel"},{"label":"Regulatory","value":"FDA cleared, NMPA cleared (China)"},{"label":"Listed on","value":"NYSE: STXS"}],"aliases":["STXS","Genesis RMN","GenesisX"],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":"STXS","stockExchange":"NYSE AMERICAN","secCik":"0001289340","revenueUsd":"32377000","revenueBasis":"disclosed","revenueAsOf":"2025-12-31T12:00:00.000Z","employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-06-03T20:13:00.997Z","updatedAt":"2026-08-21T22:28:48.492Z","jsonLd":{"@context":"https://schema.org","@type":"Organization","@id":"https://registry.deploy.report/companies/stereotaxis","url":"https://registry.deploy.report/companies/stereotaxis","name":"Stereotaxis","alternateName":["STXS","Genesis RMN","GenesisX"],"description":"Stereotaxis is an American medical device company based in St. Louis, Missouri, developing magnetic navigation technology for robotic cardiology procedures. Its [Genesis RMN](/models/genesis-rmn) system uses robotically controlled magnets to guide flexible catheters with magnetic tips during cardiac ablation procedures, and received FDA clearance and NMPA approval in China.","identifier":"e401d2c7-b035-4dea-9b60-ae0d2bb9b99b","foundingDate":"1990","address":"St. Louis, MO, USA","publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"verified","maturity_stage":null,"lifecycle_state":null,"architectural_position":{"cohort":null,"sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":3,"primary_source_types":["primary-company-ir"]}}}